Humanosphere is on hiatus. Many thanks to our web design, development and hosting partner Culture Foundry for keeping the site active while we plan our next move. Culture Foundry builds, evolves and supports next-level websites and applications for clients you know, and you couldn’t ask for a better partner to help you thrive in digital. If you’re considering an ambitious website design or development project, we encourage you to make them your very first call.

HIV Vaccine Summit: A world without AIDS

HIV, the virus
HIV, the virus
Los Alamos National Laboratory

I’m in Atlanta this week for a meeting, starting today, aimed at ridding the world of AIDS — the Global HIV Vaccine Enterprise.

A vaccine is really the only way.

After many years of frustration and even despair of ever finding an HIV vaccine, there have been some  significant, positive steps forward in the past year:

These are good signs, indicating an effective HIV vaccine is indeed possible. But we’re probably still a long way off getting one, and not just because of the scientific challenges.

As always, one of the biggest barriers is money.

We (the world community, all of us in the Humanosphere) spend less than a billion dollars a year on HIV vaccine research — as compared to the $30 billion or so we spend treating people and dealing with the still-spreading AIDS pandemic.

“And we’re not keeping up,” said Catherine Hankins of the Joint United Nations Program on HIV/AIDS (UNAIDS). “For every two people we put on treatment, another five people are still being newly infected.”

Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, said there is new momentum and optimism about finding an effective vaccine against AIDS.

“But at the same time, funding for research has dropped,” Bernstein said. He noted that the U.S. government (NIH) and the Bill & Melinda Gates Foundation today are responsible for perhaps 80 percent of the world’s funding for HIV vaccine research.

That has to change, Bernstein said, if we are to speed up the search for the only real chance the world has of beating AIDS. More and more people are still getting infected, he said, and the cost of treating them is ballooning, creating a global moral and financial crisis.

“We’re on a treadmill and the pace is picking up,” Bernstein said. Business as usual will no longer be enough to even remain in place, he said. And true progress will require much more investment in the scientific quest for a vaccine.


About Author

Tom Paulson

Tom Paulson is founder and lead journalist at Humanosphere. Prior to operating this online news site, he reported on science,  medicine, health policy, aid and development for the Seattle Post-Intelligencer. Contact him at tom[at] or follow him on Twitter @tompaulson.